Short Stocks

Nvidia’s (NVDA) Analyst Day Spotlights the Value of an Ecosystem, But the Stock Is Overvalued, Says Needham

Nvidia’s (NVDA) physical products are accelerators (for third-party hardware) and the company’s own GPU-powered workstations and servers. But it’s the company’s GPU-optimized software …

Should You Buy Cannabis Stock Hexo? “Heck, No!” Says Jefferies

Among marijuana investors, Hexo (HEXO) lacks the name recognition of an Aurora Cannabis, Canopy Growth, or Cronos Group — and according to Jefferies …

Deutsche Bank Still Sees Over 20% Downside for General Electric (GE) Stock; Here’s Why

Following its sale of its BioPharma business to Danaher, analysts and investors across the world are taking note of General Electric’s (GE) continued …

Intel (INTC) Stock Has Gotten off to a Good Start in 2019, But This Analyst Is Still Unconvinced

Intel (INTC) stock spiked late last week after a bullish rating came from Morgan Stanley for the first time in six years. Overall, …

Opinion: Stay Away from New Age Beverages (NBEV) Stock

New Age Beverages (NBEV) is a Colorado-based beverage company that has accumulated a portfolio of C-tier beverage brands primarily by acquiring other struggling …

This Analyst Sees Choppier Waters Ahead for Tesla (TSLA) Stock

Here we go again. That’s how some investors feel about Tesla (TSLA) after the electric car recently underwent a mass layoff and announced …

Analyst Targets Over 50% Downside for Netflix (NFLX) Stock; Here’s Why

For Netflix (NFLX), a key reason for developing its own original content is to lower its long-term costs. Just recently the company released …

Mohawk Industries (MHK) Stock Has a New Bear on Wall Street

Mohawk Industries (MHK) is like that driver motoring down the highway with the ever-blinking turn signal. Those following along behind are left wondering …

Bausch Health (BHC) Stock: Steadfast Bear Raises a New Alarm

Is Bausch Health (BHC) making a mistake in acquiring certain assets of Synergy Pharmaceuticals (SGYP)? Maybe — at least if you ask Wells Fargo’s David Maris.

Does Bausch Health (BHC) Stock Have a Clean and Bright Future? Not According to This Analyst

J.P Morgan’s Chris Schott recently met with Bausch Health (BHC) management to talk about the future of the pharmaceutical company.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts